VALL D’HEBRON INSTITUTE OF ONCOLOGY
Established in 2006, the Vall d´Hebron Institute of Oncology (VHIO) is a leading comprehensive cancer center of excellence where its scientists and research physicians adopt a purely translational research model, working together as multidisciplinary teams to both accelerate and advance personalized and targeted therapies against cancer. Undertaking one of Spain´s most dynamic cancer research programs, VHIO is dedicated to delivering on the promise of precision medicine in oncology – turning cancer discovery into more effective treatments and better practice for the care of our patients.
“Our mission to supply enhancements within the discipline of oncological illnesses, and translate discoveries into medical advantages is enriched by means of partnerships just like the Caris Precision Oncology Alliance. I strongly consider in becoming a member of forces, nurturing and growing partnerships, and exchanging knowledge to beat the various challenges that hamper our efforts in fixing most cancers sooner.”
– Josep Tabernero, MD, PhD
Head of Medical Oncology Department
To learn more about the Caris and Vall d’Hebron partnership click here.
- VHIO is structured into four main programs: Preclinical & Translational Research, Clinical Research, and Core Technologies.
- VHIO has a team of 300 researcher and physician scientists that focus on understanding the fundamental biology of human cancer, from cellular and molecular biology and genetics through to therapeutics.
- A total of 26 reknowned Principal Investigators manage and run VHIO’s major research themes and programs.
- VHIO is located within the campus of the Vall d´Hebron University Hospital (VHUH), the largest hospital in Barcelona and the second largest in Spain.
- VHUH houses various teaching centers, a medical school, public health facilities, research centers, laboratories and other complementary facilities.
- Since the creation of the Oncology Department at VHUH in 1995 it has undergone significant quantitative and qualitative growth in the areas of patient-care, teaching and research perspective, to become a gold-standard center in Europe.
For more information, visit: vhio.net
Vall d’Hebron Institute of Oncology